Allarity Therapeutics, Inc. Increase (Decrease) in Other Current Assets
Allarity Therapeutics, Inc. (ALLR) reported Increase (Decrease) in Other Current Assets of -$204.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentAssets · last filed 2026-08-14
- Allarity Therapeutics, Inc. increase (decrease) in other current assets for the quarter ending 2026-06-30 was -$47.00K, a 883.33% decline year-over-year.
- Allarity Therapeutics, Inc. increase (decrease) in other current assets for the quarter ending 2026-03-31 was -$157.00K.
- Allarity Therapeutics, Inc. increase (decrease) in other current assets for the quarter ending 2025-12-31 was $152.00K, a 913.33% increase year-over-year.
- Allarity Therapeutics, Inc. increase (decrease) in other current assets for the quarter ending 2025-09-30 was -$3.00K.
- Allarity Therapeutics, Inc. increase (decrease) in other current assets for fiscal 2025 was $150.00K.
- Allarity Therapeutics, Inc. increase (decrease) in other current assets for fiscal 2024 was -$94.00K.
- Allarity Therapeutics, Inc. increase (decrease) in other current assets for fiscal 2023 was -$1.35M, a 225.35% decline from fiscal 2022.
- Allarity Therapeutics, Inc. increase (decrease) in other current assets for fiscal 2022 was $1.08M, a 226.36% increase from fiscal 2021.
| Period end | Increase (Decrease) in Other Current Assets 3 month | Increase (Decrease) in Other Current Assets 6 month | Increase (Decrease) in Other Current Assets 9 month | Increase (Decrease) in Other Current Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$47.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$204.00K 10-Q · filed 2026-08-14 | -$52.00K derived: sum of 3 quarters · filed 2026-08-14 | -$55.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | -$157.00K 10-Q · filed 2026-05-15 | -$5.00K derived: sum of 2 quarters · filed 2026-05-15 | -$8.00K derived: sum of 3 quarters · filed 2026-05-15 | -$2.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $152.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $149.00K derived: sum of 2 quarters · filed 2026-03-30 | $155.00K derived: sum of 3 quarters · filed 2026-08-14 | $150.00K 10-K · filed 2026-03-30 |
| 2025-09-30 | -$3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $3.00K derived: sum of 2 quarters · filed 2026-08-14 | -$2.00K 10-Q · filed 2025-11-14 | $13.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $1.00K 10-Q · filed 2026-08-14 | $16.00K derived: sum of 3 quarters · filed 2026-08-14 | -$15.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$5.00K 10-Q · filed 2026-05-15 | $10.00K derived: sum of 2 quarters · filed 2026-05-15 | -$21.00K derived: sum of 3 quarters · filed 2026-05-15 | $0.00 derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $15.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$16.00K derived: sum of 2 quarters · filed 2026-03-30 | $5.00K derived: sum of 3 quarters · filed 2026-03-30 | -$94.00K 10-K · filed 2026-03-30 |
| 2024-09-30 | -$31.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$10.00K derived: sum of 2 quarters · filed 2025-11-14 | -$109.00K 10-Q · filed 2025-11-14 | -$929.00K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $21.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-15 | -$78.00K 10-Q · filed 2025-08-15 | -$898.00K derived: sum of 3 quarters · filed 2025-08-15 | -$1.45M derived: sum of 4 quarters · filed 2025-08-15 |
| 2024-03-31 | -$99.00K 10-Q · filed 2025-05-09 | -$919.00K derived: sum of 2 quarters · filed 2025-05-09 | -$1.48M derived: sum of 3 quarters · filed 2025-05-09 | -$1.47M derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | -$820.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$1.38M derived: sum of 2 quarters · filed 2025-03-31 | -$1.37M derived: sum of 3 quarters · filed 2025-03-31 | -$1.35M 10-K · filed 2025-03-31 |
| 2023-09-30 | -$556.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$549.00K derived: sum of 2 quarters · filed 2024-11-14 | -$530.00K 10-Q · filed 2024-11-14 | $935.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $26.00K 10-Q · filed 2024-08-05 | $1.49M derived: sum of 3 quarters · filed 2024-08-05 | $1.46M derived: sum of 4 quarters · filed 2024-08-05 |
| 2023-03-31 | $19.00K 10-Q · filed 2024-05-14 | $1.48M derived: sum of 2 quarters · filed 2024-05-14 | $1.45M derived: sum of 3 quarters · filed 2024-05-14 | $1.57M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $1.47M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $1.43M derived: sum of 2 quarters · filed 2024-03-08 | $1.55M derived: sum of 3 quarters · filed 2024-03-08 | $1.08M 10-K · filed 2024-03-08 |
| 2022-09-30 | -$33.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $82.00K derived: sum of 2 quarters · filed 2023-11-14 | -$388.00K 10-Q · filed 2023-11-14 | -$155.00K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $115.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$355.00K 10-Q · filed 2023-08-14 | -$122.00K derived: sum of 3 quarters · filed 2023-08-14 | -$336.00K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | -$470.00K 10-Q · filed 2023-05-11 | -$237.00K derived: sum of 2 quarters · filed 2023-05-11 | -$451.00K derived: sum of 3 quarters · filed 2023-05-11 | -$235.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $233.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | $19.00K derived: sum of 2 quarters · filed 2023-03-13 | $235.00K derived: sum of 3 quarters · filed 2023-03-13 | $330.00K 10-K · filed 2023-03-13 |
| 2021-09-30 | -$214.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $2.00K derived: sum of 2 quarters · filed 2022-11-14 | $97.00K 10-Q · filed 2022-11-14 | $210.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $216.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-10-07 | $311.00K 10-Q · filed 2022-10-07 | $424.00K derived: sum of 3 quarters · filed 2022-10-07 | |
| 2021-03-31 | $95.00K 10-Q · filed 2022-05-27 | $208.00K derived: sum of 2 quarters · filed 2022-05-27 | ||
| 2020-12-31 | $113.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2022-05-17 | -$510.00K 10-K · filed 2022-05-17 | ||
| 2020-09-30 | -$623.00K 10-Q/A · filed 2022-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |